Ramchandani P, Soulen R L, Schnall R I, Seidmon E J, Friedman A C, Radecki P D, Caroline D F
Urology. 1986 Jun;27(6):564-8. doi: 10.1016/0090-4295(86)90349-3.
Computerized tomography (CT), ultrasound, and angiography have been used for staging renal cell carcinoma. CT has proven to be the most reliable and sensitive of these techniques. Magnetic resonance (MR) has emerged recently as a viable alternative imaging modality. Five patients with renal cell carcinoma and suspected caval involvement were evaluated by CT, ultrasound, and MR. Caval extension and the differentiation of intra-versus retrocaval tumor was seen with greater clarity on MR scans; perinephric extension was seen equally well with both modalities. The primary tumor itself was better defined with CT. In patients with equivocal findings regarding the renal veins or inferior vena cava, MR is a valuable adjunct in preoperative evaluation. In patients at high risk for contrast administration, MR is the staging modality of choice.
计算机断层扫描(CT)、超声和血管造影已用于肾细胞癌的分期。CT已被证明是这些技术中最可靠、最敏感的。磁共振成像(MR)最近已成为一种可行的替代成像方式。对5例肾细胞癌且怀疑有腔静脉受累的患者进行了CT、超声和MR评估。在MR扫描中,腔静脉扩展以及腔静脉内与腔静脉后肿瘤的区分看得更清楚;两种检查方式对肾周扩展的显示同样良好。CT对原发肿瘤本身的显示更好。对于肾静脉或下腔静脉有可疑表现的患者,MR在术前评估中是一种有价值的辅助手段。对于有造影剂给药高风险的患者,MR是首选的分期检查方式。